19.10.2015 Views

Yttrium-90 and Rhenium-188 Radiopharmaceuticals for Radionuclide Therapy

Pub1662web-89688003

Pub1662web-89688003

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

these barriers are pH <strong>and</strong> the concentration of the base. Using strong organic<br />

bases such as triethylamine was unsuccessful. High concentrations of inorganic<br />

bases <strong>and</strong> high temperatures, however, led to hydrolysis of 2-picolyl chloride<br />

(1, see Fig. 13.1(a)) <strong>and</strong> rearrangements of the bisphosphonate [13.15]. It was<br />

found that using water as the solvent <strong>and</strong> maintaining the pH of the solution<br />

at 12 with a minimum amount of NaOH was sufficient to drive the reaction to<br />

completion after 36 h at room temperature, without detectable hydrolysis or<br />

bisphosphonate rearrangements. The yield of 3 was ><strong>90</strong>% using RP HPLC.<br />

13.2. MATERIALS AND RESULTS<br />

13.2.1. Technetium-99m <strong>and</strong> 187/185 Re studies with DPA bisphosphonate 3<br />

The complexation of 3 with fac-[Re(CO) 3 ] + , <strong>and</strong> its solution properties,<br />

were examined using HPLC (see Fig. 13.2) <strong>and</strong> nuclear magnetic resonance<br />

(NMR) spectroscopy, MS <strong>and</strong> IR spectroscopy. The aim was to determine<br />

FIG. 13.2. RP HPLC chromatograms of 3 (top left) <strong>and</strong> 3 plus increasing amounts of<br />

[Re(CO) 3 ] + .<br />

242

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!